BioStem Technologies Opens Hospital Access for VENDAJE® and VENDAJE AC® Through Vizient and Premier | BSEM Stock NewsStockTitan·Sep 4 at 03:00 AMBSEM+2.77%PINC-0.03%
BioStem Technologies Eyes Surgical Growth, Manufacturing Shift After BioTissue DealMarket Beat·Aug 22 at 01:01 AMBSEM+2.77%
BSEM: Expanding hospital market access and clinical portfolio drive growth and profitabilityQuartr·Aug 19 at 01:28 PMBSEM+2.77%
BioStem Technologies to Present at Sidoti MicroCap Virtual ConferencePUBT·Aug 14 at 08:07 PMBSEM+2.77%
BioStem Technologies shares are trading lower after the company reported a year-over-year decrease in Q2 sales results.benzinga_article·Aug 13 at 04:19 PMBSEM+2.77%
BioStem Technologies Reports Q2 2026: Revenue $7.9M, Gross Profit $4.8M, Adjusted EBITDA Loss $4.6MTradingView·Aug 12 at 09:33 PMBSEM+2.77%
BioStem Technologies, Inc. Q2 2026: Revenue $7.9M, EPS $(0.52) — 10-Q SummaryTradingView·Aug 12 at 09:11 PMBSEM+2.77%
BioStem Q2 FY26 GAAP net loss widens to $9 million; revenue rises 29% to $7.9 million vs Q1PUBT·Aug 12 at 08:13 PMBSEM+2.77%
